Survival and side effects from novel alternative regimen for squamous cell head and neck cancer.

e17515Background: Toxicity of the standard regimens is a major limitation in treatment of head/neck cancer which impacted about 61,000 persons in 2016 in USA of which 13,000 died. We present data h...